Drug Profile
Merocyanine 540
Alternative Names: pMC540; preactivated merocyanine 540Latest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Sanofi-Synthelabo
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 29 Apr 2002 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 13 Jul 1998 Profile reviewed
- 13 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)